Please join us in San Francisco for Skin Disease Education Foundation (SDEF)'s Women's & Pediatric Dermatology Seminar 2010 as we explore the chief clinical topics relevant to skin diseases in women and children. Dermatologists, pediatricians, ob/gyns and other healthcare providers who manage these conditions are invited to attend. You have the option of registering for one or both parts of the conference.
This conference is a great opportunity to catch up on the latest advances in the field. Leading experts will present clinically relevant information that you will find immediately useful in the care of your patients. You’ll learn about common and uncommon skin diseases in femaile and pediatric patients. Sessions will focus on vulvar diseases, hair loss, anti-aging, psoriasis, atopic dermatitis, acne through the ages, dermatoses, neonatology, and many more clinical topics. Interactive sessions will offer attendees the chance to ask challenging questions. Dermatology Jeopardy is featured—a very stimulating portion of the seminar that past attendees have found very useful and informative.
SDEF's Women's & Pediatrics Dermatology Seminar is held in a collegial and pleasant environment that is the hallmark of all SDEF Seminars Register today—space is limited.
We look forward to seeing you on September 24-26, 2010, at SDEF Women's & Pediatric Dermatology Seminar 2010 Grand Hyatt San Francisco.
Sheila Fallon Friedlander, MD
Clinical Professor of Pediatrics & Medicine, Dermatology
University of California, San Diego, CA
Rady Children's Hospital, San Diego, CA
Maria Hordinsky, MD
Professor, Head Department of Dermatology
University of Minnesota, Minneapolis, MN
Dermatologists, dermatology residents and other healthcare professionals.
- Apply strategies to the management of aging skin
- Evaluate and treat acne and rosacea in the female patient
- Identify best practices for the treatment of vulvar dermatoses
- Formulate approaches to the challenges of alopecia areata
- Evaluate treatment options for melasma and other conditions unique to skin of color
- Describe the safety and efficacy of biologic agents in the treatment of psoriasis
- Assess treatment approaches for the pediatric patient with common as well as complex skin diseases: acne, psoriasis, contact dermatitis and more
- Distinguish worrisome versus innocuous birthmarks
- Manage the spectrum of atopic dermatitis, from mild to moderately severe
- Recognize pediatric conditions of vitamin D
- Explain treatment of skin diseases specific to ethnic skin
Joint Sponsor Statement
This activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of the University of Louisville and Skin Disease Education Foundation, an Elsevier business. The University of Louisville is accredited by the ACCME to provide continuing medical education for physicians.
AMA PRA Credit Designation Statement
The University of Louisville School of Medicine Continuing Health Sciences Education designates this educational activity for a maximum of 19.50 AMA PRA Category 1 Credit(s)TM. Physicians should only claim credit commensurate with the extent of their participation in the activity.
This activity has been reviewed and is acceptable for up to 18.75 Prescribed Credits by the American Academy of Family Physicians
This program has been approved by the Kentucky Board of Nursing for 23.4 contact hours through the University of Louisville School of Nursing, expiration date January 31, 2013, see provider numbers below. The Kentucky Board of Nursing approval of an individual nursing education provider does not constitute endorsement of program content. Participants must attend entire session, provide license and SS#, and complete online evaluation to receive contact hours.
09/25/10 provider number 3-0046-01-2013-129 9.3
09/26/10 provider number 3-0046-01-2013-130 4.5
AAD Continuing Medical Education Recognition Award
Skin Disease Education Foundation's Women's and Pediatric Dermatology Seminar 2010, has been recognized by the AAD for 19.40 Category 1 CME credits and may be used toward the AAD Continuing Medical Education Award. Each physician should claim only those credit hours equivalent to time spent in educational sessions. There will be an attendance form which you must sign in daily to receive your CME certificate.We seek your compliance. We will collect AAD Green cards on May 15, 2010, after completion of the scientific program and return all cards to the AAD office.
As a sponsor accredited by the ACCME, it is the policy of the University of Louisville School of Medicine Continuing Health Sciences Education to require the disclosure of anyone who is in a position to control the content of an educational activity. All relevant financial relationships with any commercial interests and/or manufacturers must be disclosed to participants at the beginning of each activity.
If you need special accommodations due to a disability, or for an alternative form of course materials, please contact us at 240-221-4404 at least 14 days prior to the program. Continuing Health Sciences Education fully complies with the legal requirements of the ADA and the rules and regulations thereof.
Registrants who do not cancel according to the following guidelines will forfeit all fees. You must write, email or fax your cancellation request. There is a cancellation fee of $100 per registrant for cancellations received on or before July 20, 2010. All cancellations received after July 20, 2010 will be assessed a fifty (50%) cancellation penalty. There are no refunds for cancellations after August 20, 2010. "No shows" are not eligible for refunds.
The opinions expressed at Skin Disease Education Foundation seminars do not necessarily reflect those of Skin Disease Education Foundation, Global Academy for Medical Education, LLC, (GAME) or the supporters of the seminars. GAME will not assume responsibility for damages, loss, or claims of any kind arising from or related to the information contained in presentations, including any claims related to the products, drugs, or services mentioned.